- Home
- ZBAO vs OKUR Comparison
ZBAO vs OKUR Comparison
Compare ZBAO & OKUR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ZBAO
- OKUR
- Stock Information
- Founded
- ZBAO 2015
- OKUR 2011
- Country
- ZBAO China
- OKUR United States
- Employees
- ZBAO N/A
- OKUR N/A
- Industry
- ZBAO
- OKUR
- Sector
- ZBAO
- OKUR
- Exchange
- ZBAO NYSE
- OKUR NYSE
- Market Cap
- ZBAO 29.9M
- OKUR 34.9M
- IPO Year
- ZBAO 2024
- OKUR N/A
- Fundamental
- Price
- ZBAO $1.01
- OKUR $2.48
- Analyst Decision
- ZBAO
- OKUR Strong Buy
- Analyst Count
- ZBAO 0
- OKUR 4
- Target Price
- ZBAO N/A
- OKUR $32.25
- AVG Volume (30 Days)
- ZBAO 92.0K
- OKUR 65.6K
- Earning Date
- ZBAO 04-15-2025
- OKUR 08-14-2025
- Dividend Yield
- ZBAO N/A
- OKUR N/A
- EPS Growth
- ZBAO N/A
- OKUR N/A
- EPS
- ZBAO 0.09
- OKUR N/A
- Revenue
- ZBAO $33,673,520.00
- OKUR N/A
- Revenue This Year
- ZBAO $65.08
- OKUR N/A
- Revenue Next Year
- ZBAO $34.27
- OKUR N/A
- P/E Ratio
- ZBAO $10.87
- OKUR N/A
- Revenue Growth
- ZBAO 82.66
- OKUR N/A
- 52 Week Low
- ZBAO $0.78
- OKUR $1.70
- 52 Week High
- ZBAO $4.27
- OKUR $20.00
- Technical
- Relative Strength Index (RSI)
- ZBAO N/A
- OKUR N/A
- Support Level
- ZBAO N/A
- OKUR N/A
- Resistance Level
- ZBAO N/A
- OKUR N/A
- Average True Range (ATR)
- ZBAO 0.00
- OKUR 0.00
- MACD
- ZBAO 0.00
- OKUR 0.00
- Stochastic Oscillator
- ZBAO 0.00
- OKUR 0.00
About ZBAO ZHIBAO TECHNOLOGY INC
Zhibao Technology Inc is a insurance technology company engaged in providing digital insurance brokerage services in China. 2B2C digital embedded insurance is their business model which is pioneered in China. It provides customized digital insurance solutions for B-side channels (covering a wide range of industries and organizations, including but not limited to Internet platforms, large and medium-sized enterprises, and government agencies, etc.), embedding them into the channel's existing business matrix, and providing the channel with Provide digital insurance brokerage services to C-end customers.
About OKUR ONKURE THERAPEUTICS INC
OnKure Therapeutics Inc is a clinical-stage biopharmaceutical company focused on discovering and developing top-tier precision medicines that target biologically validated drivers of cancers that are underserved by available therapies. The company operates in one operating segment which is clinical research. It has a pipeline of tumor-agnostic candidates that are designed to achieve optimal efficacy and tolerability.